Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 221 - 230 of 472 results

First page
Previous page
Next page
Next page

PEG-30 GLYCERYL STEARATE

MW8WP96K3D

Status:

Possibly Marketed Outside US

Source:

21 CFR 352

(2015)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a5ab3c43-047b-4244-b59b-dab7e8a064e5

First approved in 2015

Source:

21 CFR 352

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a5ab3c43-047b-4244-b59b-dab7e8a064e5

Class:

POLYMER

ISOSTEARETH-20

78H2SJ8X8M

Status:

Possibly Marketed Outside US

Source:

21 CFR 350

(2015)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17919888-6130-46d2-e054-00144ff88e88

First approved in 2015

Source:

21 CFR 350

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17919888-6130-46d2-e054-00144ff88e88

Class:

POLYMER

LAURETH-20

6SU0SC83AH

Status:

Possibly Marketed Outside US

Source:

21 CFR 347

(2019)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=91465fed-556d-debb-e053-2a95a90af1a9

First approved in 2015

Source:

M016

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c1b10d34-2905-4ad6-8f90-7f9800de2b46

Class:

POLYMER

INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

9YRA9J0KI2

Status:

US Approved Rx (2015)

Source:

BLA125510

(2015)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 2015

Source:

BLA125510

Source URL:

https://www.fda.gov/media/113210/download

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

THG3PU0KOK

Status:

US Approved Rx (2015)

Source:

BLA125510

(2015)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 2015

Source:

BLA125510

Source URL:

https://www.fda.gov/media/113210/download

Class:

STRUCTURALLY DIVERSE

INFLUENZA B VIRUS B/VICTORIA/705/2018 BVR-11 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

QK2T47EPI1

Status:

US Approved Rx (2015)

Source:

BLA125510

(2015)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 2015

Source:

BLA125510

Source URL:

https://www.fda.gov/media/113210/download

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/VICTORIA/2454/2019 IVR-207 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

MZ5G0F0SAN

Status:

US Approved Rx (2015)

Source:

BLA125510

(2015)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 2015

Source:

BLA125510

Source URL:

https://www.fda.gov/media/113210/download

Class:

STRUCTURALLY DIVERSE

INFLUENZA B VIRUS B/MARYLAND/15/2016 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

OES3CXI7E9

Status:

US Approved Rx (2015)

Source:

BLA125510

(2015)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 2015

Source:

BLA125510

Source URL:

https://www.fda.gov/media/113210/download

Class:

STRUCTURALLY DIVERSE

ANTHRAX IMMUNE GLOBULIN HUMAN

VKZ83S945Z

Status:

US Approved Rx (2015)

Source:

BLA125562

(2015)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 2015

Source:

BLA125562

Source URL:

https://www.fda.gov/media/113210/download

Class:

STRUCTURALLY DIVERSE

IPOMOEA PURGA ROOT

4UDO46YBK2

Status:

US Previously Marketed

Source:

21 CFR 310.545(a)(12)(iv)(A) laxative:stimulant laxative jalap

Source URL:

https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml

First approved in 2015

Source:

PASSIFLORA PLEX by San’Up

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=937b6700-3ba8-0266-e053-2995a90a3318

Class:

STRUCTURALLY DIVERSE

Structure of PEG-30 GLYCERYL STEARATE

Polymer

PEG-30 GLYCERYL STEARATE

Structure of ISOSTEARETH-20

Polymer

Structure of LAURETH-20

Polymer

Structurally Diverse

INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA B VIRUS B/VICTORIA/705/2018 BVR-11 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/VICTORIA/2454/2019 IVR-207 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA B VIRUS B/MARYLAND/15/2016 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

ANTHRAX IMMUNE GLOBULIN HUMAN

Structurally Diverse

IPOMOEA PURGA ROOT

Showing 221 - 230 of 472 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1